Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank20
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-48.96M
↓ 33% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-36.76M
Historical baseline
PeriodValueYoY Change
TTM$-48.96M+3.2%
2024$-50.56M-9.6%
2023$-46.13M-57.5%
2022$-29.29M-50.7%
2021$-19.43M+25.8%
2020$-26.18M-